All Pharma News
Argenx isn`t sweating over Vyvgart competitors: exec

Argenx isn`t sweating over Vyvgart competitors: exec
Fraiser Kansteiner FIERCE PHARMA
10 May 2024
Share Share
UCB: Neurology Developments At AAN 2024

UCB: Neurology Developments At AAN 2024
PR NEWSWIRE
12 Apr 2024
Share Share
FDA Accepts sBLA for BIMZELX for Moderate-to-Severe Hidradenitis Suppurativa

FDA Accepts sBLA for BIMZELX for Moderate-to-Severe Hidradenitis Suppurativa
PR NEWSWIRE
04 Apr 2024
Share Share
UCB debuts first campaign for psoriasis drug Bimzelx during Oscars

UCB debuts first campaign for psoriasis drug Bimzelx during Oscars
Beth Snyder Bulik ENDPTS
12 Mar 2024
Share Share
PANTHERx® Rare Selected by UCB as the Exclusive Specialty Pharmacy for ZILBRYSQ

PANTHERx® Rare Selected by UCB as the Exclusive Specialty Pharmacy for ZILBRYSQ
PR NEWSWIRE
10 Jan 2024
Share Share
UCB departs industry trade group BIO, following Pfizer`s exit late last year

UCB departs industry trade group BIO, following Pfizer`s exit late last year
Zachary Brennan ENDPTS
04 Jan 2024
Share Share
ZILBRYSQ® (zilucoplan) Is Now Commercially Available in the U.S

ZILBRYSQ® (zilucoplan) Is Now Commercially Available in the U.S
PR NEWSWIRE
03 Jan 2024
Share Share
UCB presents new data about the real-world experience of FINTEPLA

UCB presents new data about the real-world experience of FINTEPLA
PR NEWSWIRE
02 Dec 2023
Share Share
UCB Announces U.S. Availability of BIMZELX® for Plaque Psoriasis

UCB Announces U.S. Availability of BIMZELX® for Plaque Psoriasis
PR NEWSWIRE
14 Nov 2023
Share Share
Post Hoc Analysis Showed CIMZIA Resulted in Meaningful Efficacy for RA Patients

Post Hoc Analysis Showed CIMZIA Resulted in Meaningful Efficacy for RA Patients
PR NEWSWIRE
11 Nov 2023
Share Share